LEAH BRUNIE: Open Payments
NPI 1710284310 · SEATTLE, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,129 in 48 payments from 13 companies in 2025. Trend: 2023 $738 · 2024 $426 · 2025 $1,129
Food & beverage: $1,029Education: $100
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 13 | $248 |
| REVANCE THERAPEUTICS, INC. | 3 | $180 |
| ABBVIE INC. | 7 | $176 |
| Novartis Pharmaceuticals Corporation | 5 | $130 |
| UCB, Inc. | 6 | $117 |
| GENZYME CORPORATION | 4 | $79 |
| Arcutis Biotherapeutics, Inc. | 2 | $44 |
| Almirall LLC | 1 | $34 |
| LEO Pharma Inc. | 2 | $30 |
| STRATA Skin Sciences, Inc. | 2 | $26 |
Products named: TREMFYA, DAXXIFY, RINVOQ, Bimzelx, DUPIXENT, COSENTYX, Rhapsido, Zoryve.
Industry payments across WA — which companies pay providers there.
